These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 15937645

  • 1. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
    Uematsu M, Ohsawa I, Aokage T, Nishimaki K, Matsumoto K, Takahashi H, Asoh S, Teramoto A, Ohta S.
    J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645
    [Abstract] [Full Text] [Related]

  • 2. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF, Hamilton RL, Burnham J, Holmes EJ, Finkelstein SD, Sposto R, Yates AJ, Boyett JM, Finlay JL.
    Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
    [Abstract] [Full Text] [Related]

  • 3. [Nuclear expression of Survivin in glioma and its correlation to prognosis].
    Pan Y, Hu WH, Xie D, Wu HX, Xiang J, Liu YD, Wu QL, Liu YH.
    Ai Zheng; 2006 May; 25(5):635-9. PubMed ID: 16687089
    [Abstract] [Full Text] [Related]

  • 4. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D, Blanco C, Friedlander DR, Miller DC, Newcomb EW.
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [Abstract] [Full Text] [Related]

  • 5. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker.
    Saito T, Arifin MT, Hama S, Kajiwara Y, Sugiyama K, Yamasaki F, Hidaka T, Arita K, Kurisu K.
    J Neurooncol; 2007 Apr; 82(2):193-8. PubMed ID: 17151933
    [Abstract] [Full Text] [Related]

  • 6. Prognostic Value of ALDH1, EZH2 and Ki-67 in Astrocytic Gliomas.
    Ahmed S, Rashed H, Hegazy A, Mohamed AM, Elmesallamy W.
    Turk Patoloji Derg; 2016 Apr; 32(2):70-81. PubMed ID: 27136105
    [Abstract] [Full Text] [Related]

  • 7. [Nuclear and cytoplasmic expressions of survivin in glioma and their prognostic value].
    Pan Y, Hu WH, Xie D, Wu QL, Liu YH, Xiang J, Wu HX.
    Zhonghua Yi Xue Za Zhi; 2007 Jan 30; 87(5):325-9. PubMed ID: 17456361
    [Abstract] [Full Text] [Related]

  • 8. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
    Zhen HN, Zhang X, Hu PZ, Yang TT, Fei Z, Zhang JN, Fu LA, He XS, Ma FC, Wang XL.
    Cancer; 2005 Dec 15; 104(12):2775-83. PubMed ID: 16284993
    [Abstract] [Full Text] [Related]

  • 9. No prognostic impact of survivin expression in glioblastoma.
    Preusser M, Gelpi E, Matej R, Marosi C, Dieckmann K, Rössler K, Budka H, Hainfellner JA.
    Acta Neuropathol; 2005 May 15; 109(5):534-8. PubMed ID: 15843906
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas.
    Taniguchi K, Wakabayashi T, Yoshida T, Mizuno M, Yoshikawa K, Kikuchi A, Nakashima N, Yoshida J.
    J Neurosurg; 1999 Sep 15; 91(3):477-82. PubMed ID: 10470824
    [Abstract] [Full Text] [Related]

  • 11. ACTC1 as an invasion and prognosis marker in glioma.
    Ohtaki S, Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, Oka S, Noshiro S, Akiyama Y, Mikami T, Mikuni N, Kocsis JD, Honmou O.
    J Neurosurg; 2017 Feb 15; 126(2):467-475. PubMed ID: 27081897
    [Abstract] [Full Text] [Related]

  • 12. Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades.
    Lebelt A, Rutkowski R, Och W, Jaczun K, Dziemiańczyk-Pakieła D, Milewski R, Mariak Z, Reszeć J.
    Adv Med Sci; 2016 Sep 15; 61(2):237-243. PubMed ID: 26995334
    [Abstract] [Full Text] [Related]

  • 13. Proliferation index as a predictor of prognosis in malignant gliomas of childhood.
    Pollack IF, Campbell JW, Hamilton RL, Martinez AJ, Bozik ME.
    Cancer; 1997 Feb 15; 79(4):849-56. PubMed ID: 9024724
    [Abstract] [Full Text] [Related]

  • 14. Application of flow cytometry for evaluating clinical prognosis and histopathological grade of human glioma.
    Lin YW, Tai SH, Chang CC, Chao LC, Wen MJ, Huang YH, Hung HY, Lee EJ.
    Neurol Res; 2016 Jul 15; 38(7):625-33. PubMed ID: 27264544
    [Abstract] [Full Text] [Related]

  • 15. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas.
    Hsu DW, Louis DN, Efird JT, Hedley-Whyte ET.
    J Neuropathol Exp Neurol; 1997 Aug 15; 56(8):857-65. PubMed ID: 9258255
    [Abstract] [Full Text] [Related]

  • 16. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L, Colli BO, Machado HR, Carlotti CG, Santos AC, Chimelli L.
    Clin Neuropathol; 2004 Aug 15; 23(6):262-70. PubMed ID: 15584210
    [Abstract] [Full Text] [Related]

  • 17. RIZ1: a potential tumor suppressor in glioma.
    Zhang C, Zhu Q, He H, Jiang L, Qiang Q, Hu L, Hu G, Jiang Y, Ding X, Lu Y.
    BMC Cancer; 2015 Dec 21; 15():990. PubMed ID: 26690953
    [Abstract] [Full Text] [Related]

  • 18. Quantitatively determined survivin expression levels are of prognostic value in human gliomas.
    Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS.
    J Clin Oncol; 2002 Feb 15; 20(4):1063-8. PubMed ID: 11844831
    [Abstract] [Full Text] [Related]

  • 19. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas.
    Liu B, Pang B, Hou X, Fan H, Liang N, Zheng S, Feng B, Liu W, Guo H, Xu S, Pang Q.
    Hum Pathol; 2014 Aug 15; 45(8):1752-8. PubMed ID: 24935062
    [Abstract] [Full Text] [Related]

  • 20. Survivin in brain tumors: an attractive target for immunotherapy.
    Katoh M, Wilmotte R, Belkouch MC, de Tribolet N, Pizzolato G, Dietrich PY.
    J Neurooncol; 2003 Aug 15; 64(1-2):71-6. PubMed ID: 12952288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.